/K I L L K I L L K I L L -- Roche/

Saturday, May 10, 2008 General News
Email Print This Page Comment
Font : A-A+

We are advised by Roche US that journalists and other readers shouldplease disregard the news release, New Study Demonstrates ACTEMRA(R)(tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid ArthritisPatients, issued earlier today over PR Newswire.

SOURCE Roche


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook